Taro Pharmaceutical Industries Ltd.
Topical montelukast for treatment of atopic dermatitis
Last updated:
Abstract:
A topical formulation comprising Montelukast or a pharmaceutically acceptable salt thereof, a gelling agent and water for the treatment of atopic dermatitis.
Status:
Grant
Type:
Utility
Filling date:
3 May 2017
Issue date:
4 Feb 2020